Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Clinical Neuropharmacology|October 1, 1991
Acute dystonia induced by sulpirideG Linazasoro, J F Martí Massó, B OlasagastiParkinsonism & Related Disorders|July 6, 2010
Classifying risk factors for dyskinesia in Parkinson's diseaseJ C Sharma, C G Bachmann, G LinazasoroNeurology|September 26, 2002
Predictors of effective bilateral subthalamic nucleus stimulation for PDP D Charles, N Van Blercom, P Krack, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Nocturnal akathisia in Parkinson's disease: treatment with clozapineG Linazasoro, J F Martí Massó, J A SuárezJournal of Neural Transmission (Vienna, Austria : 1996)|April 2, 2004
Pharmacological and PET studies in patient's with Parkinson's disease and a short duration-motor response: implications in the pathophysiology of motor complicationsG Linazasoro, A Antonini, R P Maguire, et al.Neurocirugia (Asturias, Spain)|May 27, 2008
[Spinal cord compression due to a epidural lipoma]E Urculo, N Samprón, R Alfaro, et al.Clinical Neuropharmacology|April 15, 1999
Controlled release levodopa in Parkinson's disease: influence of selection criteria and conversion recommendations in the clinical outcome of 450 patients. STAR Study GroupG Linazasoro, F Grandas, P Martínez Martín, et al.Neurologia (Barcelona, Spain)|November 26, 1999
Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile. The STAR Study GroupP Martínez-Martín, F Grandas, G Linazasoro, et al.Neurologia (Barcelona, Spain)|August 1, 1990
[Parkinsonism after methyl alcohol poisoning]B Indakoetxea, A López de Munain, J F Martí-Massó, et al.Neurosurgery|August 17, 1999
Stereotactic targeting of the globus pallidus internus in Parkinson's disease: imaging versus electrophysiological mappingJ Guridi, A Gorospe, E Ramos, et al.Pageof 6